Titus B. Ball - 11 Jun 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: Principal Accounting Officer
Issuer ticker: ONC
Reported as of: 11 Jun 2026
Net transaction value: -$43,467
SEC form: 4
Accepted by SEC: 15 Jun 2026, 17:55:36 UTC
Prior SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Qing Nian, as Attorney-in-Fact

Key filing fact

Titus B. Ball filed Form 4 for BeOne Medicines Ltd. (ONC) on 15 Jun 2026.

Key facts

This page summarizes Titus B. Ball's Form 4 filing for BeOne Medicines Ltd. (ONC).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 17:55.

Change

Previous filing in this sequence was filed on 10 Jun 2026.
Current net transaction value: -$43,467.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001675628 Primary reporting owner

Ball Titus B.

Relationship: Principal Accounting Officer
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Qing Nian, as Attorney-in-Fact
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

Ordinary Shares

Award

Transaction value
Shares: +31,213
Change %: +46%
Price: $0.000000^*
Shares after: 99,645
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

ONC transaction

American Depositary Shares

Sale

Transaction value: $12,563
Shares: -49
Change %: -29%
Price: $256.39
Shares after: 120
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F2, F3

ONC transaction

American Depositary Shares

Sale

Transaction value: $30,904
Shares: -120
Change %: -100%
Price: $257.53
Shares after: 0
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Footnote F2

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F3

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service.